Sensitivity to tumor development by TALEN-mediated Trp53 mutant genes in the susceptible FVB/N mice and the resistance C57BL/6 mice
Authors:
Open Access
- 29 November 2021
- journal article
- research article
- Published by Springer Nature in Laboratory Animal Research
- Vol. 37 (1) , 1-13
Abstract
Background: This study was undertaken to compare the sensitivities of mice strains during tumor induction by transcription activator-like effector nucleases (TALEN)-mediated Trp53 mutant gene. Alterations of their tumorigenic phenotypes including survival rate, tumor formation and tumor spectrum, were assessed in FVB/N-Trp53em2Hwl/Korl and C57BL/6-Trp53em1Hwl/Korl knockout (KO) mice over 16 weeks. Results: Most of the physiological phenotypes factors were observed to be higher in FVB/N-Trp53em2Hwl/Korl KO mice than C57BL/6-Trp53em1Hwl/Korl KO mice, although there were significant differences in the body weight, immune organ weight, number of red blood cells, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelet count (PLT), total bilirubin (Bil-T) and glucose (Glu) levels in the KO mice relative to the wild type (WT) mice. Furthermore, numerous solid tumors were also observed in various regions of the surface skin of FVB/N-Trp53em2Hwl/Korl KO mice, but were not detected in C57BL/6-Trp53em1Hwl/Korl KO mice. The most frequently observed tumor in both the Trp53 KO mice was malignant lymphoma, while soft tissue teratomas and hemangiosarcomas were only detected in the FVB/N-Trp53em2Hwl/Korl KO mice. Conclusions: Our results indicate that the spectrum and incidence of tumors induced by the TALEN-mediated Trp53 mutant gene is greater in FVB/N-Trp53em2Hwl/Korl KO mice than C57BL/6-Trp53em1Hwl/Korl KO mice over 16 weeks.Keywords
Funding Information
- biorein (laboratory animal bio resources initiative) from the ministry of food and drug safety
This publication has 22 references indexed in Scilit:
- Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor GenesClinical Medicine Insights: Oncology, 2011
- Tumor Suppressive Functions of p53Cold Spring Harbor Perspectives in Biology, 2009
- p53 isoforms can regulate p53 transcriptional activityGenes & Development, 2005
- Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous MiceThe American Journal of Pathology, 2000
- Effects of genetic background on tumorigenesis in p53‐deficient miceMolecular Carcinogenesis, 1995
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Spontaneous and carcinogen–induced tumorigenesis in p53–deficient miceNature Genetics, 1993
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- p53 Mutations in Human CancersScience, 1991
- Identification of p53 as a Sequence-Specific DNA-Binding ProteinScience, 1991